Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: A randomised, multicentre, controlled study

Journal of Human Hypertension

Volumn 17, Issue 2, 2003, Pages 139-146

  Rosei, E A ^a   Rizzoni, D ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Blood pressure; Captopril; Clinical trials; Delapril; Hydrochlorothiazide; Indapamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CHOLESTEROL; CREATININE; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; TRIACYLGLYCEROL; UREA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DISEASE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PARALLEL DESIGN; PATIENT SELECTION; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SODIUM BLOOD LEVEL; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TABLET; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDANS; INDAPAMIDE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0037291361     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001514     Document Type: Article

References (25)

1. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
2. Neaton JD, Grimm RH, Prineas RJ. Treatment of Mild Hypertension Study (TOMHS): Final results. JAMA 1993; 270: 713-724.
3. Brown MJ et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-372.
4. Müller FB, Laragh JH. Issues, goals and guidelines for choosing first-line and combination antihypertensive drug therapy. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Treatment. Raven Press: New York, 1990, pp 2107-2115.
5. Kaplan NM. Treatment of hypertension: Drug therapy. In: Kaplan NM (ed). Clinical Hypertension. Williams & Wilkins: Baltimore, 1986, pp 180-272.
6. Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypotension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
7. Ambrosioni E, Borghi C, Costa FV. Captopril and hydrochlorothiazide: Rationale for their combination. J Clin Pharmacol 1987; 23 (Suppl): 43-50.
8. Mersey J, D'Hemecourt P, Blase K. Once-daily combination of captopril and hydrochlorothiazide as first line therapy for mild to moderate hypertension. Curr Ther Res 1993; 53: 502-512.
9. Rappelli A. Controlling hypertension: Lisinopril-hydrochlorothiazide. An Italian multicenter study. J Hum Hypertens 1991; 5 (Suppl 2): 55-58.
10. Richard V et al. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: Haemodynamic, biological and structural effects. J Hypertens 1996; 14: 1447-1454.
11. Lucioni R et al. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. J Hypertens 1995; 13: 1847-1851.
12. Razzetti R, Fornasier M, Papotti M, Bongrani S. Antihypertensive and diuretic effects of delapril, indapamide and their combination in spontaneously hypertensive rats. High Blood Pressure 1994: 3 (Suppl 4): 8-15.
13. Rappelli A et al. Delapril and indapamide combination therapy in hypertensive patients: A double-blind randomized multicenter study. High Blood Pressure 1994: 3 (Suppl 4): 34-38.
14. Leonetti G, Efficacia antiipertensiva dell'associazione delaprilindapamide: Delapril-Indapamide Multicenter Study (DIMS). Cardiologia 1997; 42 (Suppl 3): 401-406.
15. Abbou CB. The efficacy and tolerability of indapamide in essential hypertension: A multicentre study in 981 patients. Curr Med Res Opin 1985; 9: 494-499.
16. Leonetti G. Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. Am J Med 1988; 84 (Suppl 1B): 59-64.
17. Leenen FHH. Indapamide and vascular reactivity. Drugs Today 1989; 25 (Suppl 11): 27-35.
18. Bevilacqua M et al. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries and veins. J Cardiovasc Pharmacol 1996; 28: 494-499.
19. Oka Y. Delapril. Cardiovasc Drug Rev 1988; 6: 192-205.
20. Lechi A, Arosio E. Clinical study of the efficacy and tolerability of combined delapril-indapamide in hypertension. High Blood Pressure 1994; 3 (Suppl 4): 39-45.
21. Fogari R et al. Determination of the optimal dosage of the delapril-indapamide combination in the treatment of mild to moderate arterial hypertension: A multicentre, controlled, double-blind study on parallel group. High Blood Pressure 1994; 3 (Suppl 4): 26-33.
22. Raggi U. Indapamide in the treatment of hypertension in non-insulin dependent diabetes. Hypertension 1985; 7 (Suppl II): 157-160.
23. Zanchetti A et al. on behalf of the ELISA investigators. Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16: 949-961.
24. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-564.
25. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17: 1065-1072.